Chernobyl, 25 Years Later: Lessons for Japan?
April 27, 2011 in CancerOn the 25th anniversary of the Chernobyl nuclear disaster, a comment published by Lancet Oncology describes the known health consequences of the 1986 event. The authors are Kirsten B. Moysich, PhD, MS, and Philip McCarthy, Jr., MD, both of Roswell Park Cancer Institute (RPCI), and Per Hall, PhD, of Karolinska Institute, Stockholm, Sweden who have contributed to numerous scholarly articles on this topic, including the first major United Nations Report into the effects of the Chernobyl accident in 2000.
Dr. Moysich is Professor of Oncology in the Department of Cancer Prevention and Control and Professor and Academic Program Chair of the Department of Cancer Pathology and Prevention at RPCI, and Dr. McCarthy is a Professor of Oncology and Director of the Institutes Blood & Marrow Transplant Program.
The authors point out that there were many obstacles in studying the aftermath of the Chernobyl accident and that the Fukushima incident might offer a new, albeit sad, opportunity to more accurately study the health consequences of a major nuclear-power-plant accident. The authors attribute this to the greater scientific expertise in Japan, as well as the greater economic and political stability.
Radioactive elements with a long half-life (the time it takes for half the sample to decay), especially caesium and strontium, will be prevalent in the environment for decades to come. Radioactive iodine, despite having a half-life of just eight days, can cause damage by being absorbed into the body through food, where it is stored in the thyroid gland. An increased risk of childhood thyroid cancer (3 to 8 times higher) among those with the highest exposures was seen post-Chernobyl in affected areas. This has led to recommendations to distribute potassium iodine tablets to children and adolescents in the most contaminated areas following a nuclear-power-plant accident. Unfortunately, no chemoprotective interventions are available for radiation exposure from caesium or strontium. The authors say: Aggressive efforts will be needed to limit exposure to radioactive iodine and caesium, and to isolate contaminated areas. In particular, children and young adults are at highest risk because of past data showing that exposure at young ages increases the risk of adverse health effects such as thyroid cancer.
They also discuss the potential harmful effect of radiation for girls in puberty. Evidence from the Japanese Life Span Study (which looked at radiation related risk factors following detonation of atomic bombs in World War II) suggested that the highest excess risk for breast cancer was for women who were in puberty at the time of the atomic bombing. The authors say: Another sensitive time-point is lactation at the time of the accident, when the likelihood of radionuclide absorption to the mammary tissue is high.
Dr. Moysich and colleagues conclude that the documented cancer consequences of the Chernobyl accident were restricted to thyroid cancer in children and were much lower than first expected. Due to the many issues associated with studying Chernobyl health effects, results from new studies focusing on the Fukushima incident might uncover more accurate estimates of the aftermath of nuclear power plant accidents in the past and present, as well as provide useful information for the public health management of future events.
More information: For more information, visit http://www.thelanc … 1470-2045(11)70095-X/abstract
Provided by Roswell Park Cancer Institute
-
No drop in Chernobyl cancer risk: US study
Mar 17, 2011 |
not rated yet |
0
-
Increase in cancer in Sweden can be traced to Chernobyl
May 30, 2007 |
not rated yet |
0
-
Scientists lack complete answers on radiation risk
Mar 21, 2011 |
not rated yet |
0
-
Questions and answers: Japan, Chernobyl disasters
Apr 12, 2011 |
not rated yet |
0
-
Fears of health risks rise amid Japan crisis
Mar 15, 2011 |
not rated yet |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (3) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
Your brain on 'shrooms: fMRI elucidates neural correlates of psilocybin psychedelic state
Feb 29, 2012 |
4.9 / 5 (41) |
45
-
Your brain on dye: Imaging neuronal voltage with fluorescent sensors and molecular wires
Feb 24, 2012 |
4.9 / 5 (9) |
0
-
Understanding the mechanisms of disease .
May 14, 2012
-
Short burst of hypersensitivity disorder?
May 13, 2012
-
Copper aspirinate
May 12, 2012
-
Ultraviolet rays and diseases
May 12, 2012
-
Article: Robot Reveals the Inner Workings of Brain Cells
May 11, 2012
-
Recommend to me the textbook on an inflammation, please
May 08, 2012
- More from Physics Forums - Medical Sciences
More news stories
Hormone-depleting drug shows promise against localized high-risk prostate tumors
A hormone-depleting drug approved last year for the treatment of metastatic prostate cancer can help eliminate or nearly eliminate tumors in many patients with aggressive cancers that have yet to spread beyond the prostate, ...
Cancer
4 hours ago |
5 / 5 (1) |
0
Experimental agent may help older people with chronic leukemia
The experimental drug ibrutinib (PCI-32765) shows great promise for the treatment of elderly patients with chronic lymphocytic leukemia (CLL), according to interim findings from a clinical trial.
Cancer
4 hours ago |
not rated yet |
0
Phase I study of temsirolimus, capecitabine proves safe; positive survival trend seen
A phase I clinical trial examining the safety of combining temsirolimus and capecitabine in advanced malignancies suggests the two agents can be given safely to patients. In addition, the Georgetown Lombardi Comprehensive ...
Cancer
4 hours ago |
5 / 5 (1) |
0
Revised glioblastoma classification should improve patient care
Radiation oncology researchers have revised the system used by doctors since the 1990s to determine the prognosis of people with glioblastoma, which is the most devastating of malignant brain tumors.
Cancer
4 hours ago |
not rated yet |
0
Study combines lapatinib with cetuximab to overcome resistance in EGFR-driven tumors
Targeted therapies have been studied for years, but recent laboratory research is providing robust clues about drugs that might work better in combination, particularly in treating cancers that have become resistant to therapy. ...
Cancer
4 hours ago |
not rated yet |
0
Paralyzed individuals control robotic arms to reach and grasp using brain computer interface (w/ Video)
In an ongoing clinical trial, a paralyzed woman was able to reach for and sip from a drink on her own for the first time in nearly 15 years by using her thoughts to direct a robotic arm. The ...
Zebrafish study isolates gene related to autism, schizophrenia and obesity
What can a fish tell us about human brain development? Researchers at Duke University Medical Center transplanted a set of human genes into a zebrafish and then used it to identify genes responsible for head ...
ApoE4 Alzheimer's gene causes brain's blood vessels to leak, die
Common variants of the ApoE gene are strongly associated with the risk of developing late-onset Alzheimer's disease, but the gene's role in the disease has been unclear. Now, researchers funded by the National ...
Landscape of cancer genes and mutational processes in breast cancer
In a study published today in Nature, researchers describe nine new genes that drive the development of breast cancer. This takes the tally of all genes associated with breast cancer development to 40.
Experts say psychiatry's diagnostic manual needs overhaul
The Diagnostic and Statistical Manual of Mental Disorders (DSM), long the master reference work in psychiatry, is seriously flawed and needs radical change from its current "field guide" form, according to an essay by two ...
Study finds common antibiotic azithromycin carries heart risk
Vanderbilt researchers have discovered a rare, but important risk posed by the antibiotic azithromycin, commonly called a "Z-pack." The study found a 2.5-fold higher risk of death from cardiovascular death in the first five ...